Oragenics (OGEN) Stock Statistics & Valuation Metrics

Oragenics has a market cap or net worth of $4.83M. The enterprise value is $4.95M.

Oragenics has 4,127,173 shares outstanding. The number of shares has decreased by -2.65% in one year.

Oragenics’s return on equity (ROE) is 49.88 and return on invested capital (ROIC) is -9052.41%.

The current PE Ratio of Oragenics is ―. Oragenics’s PEG ratio is ―.

In the last 12 months, Oragenics had revenue of 0.00 and earned -10.57M in profits. Earnings per share was -1.60.

In the last 12 months, operating cash flow was -7.42M and capital expenditures 3.00, giving a free cash flow of -7.42M billion.

Oragenics pays an annual dividend of ―, resulting in a dividend yield of ―

Oragenics upcoming earnings date is ―, ―.

Oragenics as a current ratio of 0.87, with Debt / Equity ratio of -141.00%

In the past 12 months, Oragenics has paid 0.00 in taxes.

Oragenics EV to EBITDA ratio is -6.90, with an EV/FCF ratio of -8.47.

Oragenics has $1.97M in cash and marketable securities with $3.00M in debt, giving a net cash position of $1.03M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Oragenics is ―, which is 11.43% higher than the current price. The consensus rating is ―